Shoulder Dislocation: Assessment of Lesions, Trajectories and Outcomes (SALTO)

NCT07486440 · tracked via the Priya Life Science Norway tracker

Sponsor

Oslo University Hospital

Phase

Observational

Started

2026-04-15

Last updated

2026-03-20

Condition(s) studied

Anterior Shoulder DislocationShoulder Dislocation Closed TraumaticFirst Time Shoulder DislocationShoulder InstabilityHill Sach LesionBankart Lesion

Study summary

The goal of this prospective observational cohort study is to provide epidemiological and prognostic data from a defined urban population and to improve understanding of risk factors and long-term outcomes following first-time anterior shoulder dislocation in patients aged 16 years and older presenting to the Oslo Accident and Emergency Outpatient Clinic.

The main questions the study aims to answer are:

* What is the incidence of first-time anterior shoulder dislocations in the Oslo region?
* What is the prevalence and extent of bipolar bone loss and soft tissue injuries measured by CT and MR after a first-time shoulder dislocation?
* Does bone loss increase the risk of recurrent shoulder instability?
* How do imaging findings and recurrence influence long-term shoulder function and quality of life?

Participants will:

* Undergo standard clinical evaluation and conventional radiographs as part of routine care and asked to participate and followed longitudinally
* Be offered additional CT and MRI imaging to assess glenoid and humeral bone loss and to evaluate soft tissue injuries.
* Complete electronic questionnaires (WOSI, EQ-5D-5L, pain score, Rowe score, return to sport/work) at 3 months, 1 year, 5 years, and 10 years.
* Be invited to long-term follow-up, including radiographs at 10 years to evaluate signs of osteoarthritis.

Eligibility

Sex

ALL

Min age

16 Years

Max age

—

Healthy volunteers

Inclusion Criteria * Age ≥16 years * Diagnosis of first-time traumatic anterior shoulder dislocation * Resident in the Oslo region who presents to Oslo Accident and Emergency Outpatient Clinic for treatment or follow-up within two weeks after initial injury * Ability to provide informed consent Exclusion Criteria * Previous shoulder dislocation requiring reduction (Patients uncertain about prior dislocation are excluded) * Age \< 16 years * Chronic substance abuse affecting compliance * Inability to understand Norwegian or English * Adult not able to provide consent or severe medical or psychiatric condition precluding follow-up

Primary outcome measure(s)

Epidemiology of first time shoulder dislocations in Oslo, Norway — From enrollment through completion of inclusion, an average of 2 years
Incidence of first-time anterior shoulder dislocations in the Oslo region and prevalence of bipolar bone loss and soft tissue injuries assessed by CT and MRI
Prevalence of bipolar bone loss assessed by CT — Baseline
Presence and extent of bipolar bone loss (glenoid bone loss and Hill-Sachs lesion) assessed using computed tomography (CT)
Prevalence of soft tissue injury assessed by MRI — Baseline
Presence of soft tissue injuries (e.g., Bankart lesion, ALPSA lesion, HAGL lesion, SLAP lesion, rotator cuff injury) assessed using magnetic resonance imaging (MRI).

Trial sites (1)

Facility	City	Region	Status
Oslo University Hospital	Oslo	Norway

More Oslo University Hospital trials in Norway

Cervical Radiculopathy Trial Active, not recruiting

Nutrition Therapy in the Immature Infant (ImNuT) Active, not recruiting

The HIP Self-management Study Active, not recruiting

Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation Recruiting

Natural History Study of Retinitis Pigmentosa Type 11 Active, not recruiting

Other trials for the same condition

Anterior Shoulder Instability Treated With a Semitendinosus Subscapular Sling Procedure Active, not recruiting

Stabilization of the Shoulder Joint Using a Latarjet-like Procedure. Enrolling by invitation

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07486440 on ClinicalTrials.gov ↗ ← All trials in Norway